← Back to Search

Educational Videos for Sexual Health in Breast Cancer

N/A

Waitlist Available

Led By Sarah E Tevis, MD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Stage I-III invasive breast cancer within one month of initial multi-disciplinary clinic visit or surgical consultation

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to evaluate whether an educational video series for breast cancer patients is acceptable, appropriate, and feasible to use during their treatment.

Who is the study for?

This trial is for women within one month of their first visit or surgical consult for Stage I-III invasive breast cancer. Participants must be able to complete surveys on their own and read and speak English. They should also be willing to follow the study's procedures.

What is being tested?

The trial is evaluating an educational video series designed for patients undergoing breast cancer treatment, focusing on its acceptability, appropriateness, and feasibility as a supportive resource.

What are the potential side effects?

Since this intervention involves educational videos, there are no direct medical side effects associated with it. However, participants may experience emotional or psychological responses to the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was diagnosed with Stage I-III breast cancer less than a month ago.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the educational video series after six-months of access and use by breast cancer patients as measured by AIM instrument.

Appropriateness of the educational video series after six-months of access and use by breast cancer patients as measured by IAM instrument.

Determine the sustainability of the educational video series after six-months of access and use by breast cancer patients as measured by the FIM instrument.

Secondary study objectives

Change from baseline in sexual health and function at six-months, as measured by the PROMIS Sexual Function v2 Brief Profile (Female)